Advantages and limitations of experimental techniques used to measure cardiac energy metabolism

Journal of Nuclear Cardiology

Volumn 4, Issue 4, 1997, Pages 316-328

  Lopaschuk, Gary D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Fatty acids; Glucose; Mitochondria; Positron emission tomography; Tricarboxylic acid cycle

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARBOHYDRATE; CARBON; CARBON 11; CARBON 14; FATTY ACID; FLUORODEOXYGLUCOSE F 18; HEART ENZYME; LACTIC ACID; TRITIUM;

AEROBIC METABOLISM; ANIMAL TISSUE; CARBON NUCLEAR MAGNETIC RESONANCE; CITRIC ACID CYCLE; CORONARY SINUS; DISEASE SEVERITY; ENERGY METABOLISM; EXPERIMENTATION; FATTY ACID OXIDATION; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART CATHETERIZATION; HEART CONTRACTION; HEART DISEASE; HEART MITOCHONDRION; HEART MUSCLE METABOLISM; HUMAN; HUMAN TISSUE; HYDROLYSIS; ISOTOPE LABELING; MEASUREMENT; METABOLITE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE PHOSPHORYLATION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW;

EID: 0030870306     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(97)90110-0     Document Type: Review

References (50)

1. Bing RJ. Cardiac metabolism. Physiol Rev 1964;45:171-213.
2. Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 1974;36:413-59.
3. Randle PJ. Fuel selection in animals. Biochem Soc Trans 1986; 14:799-806.
4. Saddik M, Lopaschuk GD. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem 1991;266:8162-70.
5. Lopaschuk GD, Belke DD, Gamble J, et al. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochem Biophys Acta 1994;1213:263-76.
6. Lopaschuk GD. Abnormal mechanical function in diabetes: relationship to altered myocardial carbohydrate/lipid metabolism. Coron Artery Dis 1996;7:116-23.
7. Stanley WC, Lopaschuk GD, Hall JL, et al. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions: potential for pharmacological interventions. Cardiovasc Res. 1997;33:243-57.
8. Lopaschuk GD. How can fatty acid and carbohydrate metabolism be manipulated? Dialog Cardiovasc Med 1996;1:93-8.
9. Wisneski JA, Stanley WC, Neese RA, et al. Effects of acute hyperglycemia on myocardial glycotic activity in humans. J Clin Invest 1990;85:1648-56.
10. 13C3] lactate: a new approach for investigating human myocardial metabolism during ischemia. J Am Coll Cardiol 1985;5:1138-46.
11. Randle PJ, Newsholme EA, Garland PB. Regulation of glucose uptake by muscle: effects of fatty acids, ketone bodies and pyruvate and of alloxan-diabetes and starvation on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. Biochem J 1963;93:652-65.
12. Randle PJ, Hales CN, Garland PB, et al. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetic mellitus. Lancet 1963;1:785-9.
13. Awaan AA, Saggerson ED. Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem J 1993;295:61-6.
14. Saddik M, Gamble J, Witters LA, Lopaschuk GD. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem 1993;268:25836-45.
15. Lopaschuk D, Spafford MA, Davies NJ, et al. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res 1990;66:546-53.
16. Saddik M, Lopaschuk GD. Myocardial triglyceride turnover during reperfusion of isolated rat hearts subjected to a transient period of global ischemia. J Biol Chem 1992;267:3825-31.
17. Benzi RH, Lerch R. Dissociation between contractile function and oxidative metabolism in postischemic myocardium. Circ Res 1992;71:567-76.
18. Liedtke AJ, DeMaison L, Eggleston AM, Cohen LM, Nellis SH. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res 1988;62:535-42.
19. Nascimben L, Friedrich J, Liao R. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. Circulation 1995;91:1824-33.
20. Ingwall JS. Is cardiac failure a consequence of decreased energy reserve? Circulation 1993;87:58-62.
21. Zhang J, Duncker DJ, YA X, et al. Effect of left ventricular hypertrophy secondary to chronic pressure overload on transmural myocardial 2-deoxyglucose uptake. Circulation 1995;92:1274-83.
22. 2 consumption during reperfusion of ischemia rat hearts. Am J Physiol 1996;270:H72-80.
23. Renstrom B, Liedtke AJ, Nellis SH. Mechanisms of substrate preference for myocardial reperfusion oxidative metabolism during early myocardial reperfusion. Am J Physiol 1990;28:H317-23.
24. 14C] fatty acid oxidation. Biochem Med Metab Biol 1986;35:248-59.
25. Lopaschuk G, Hansen CA, Neely JR. Fatty acid metabolism in hearts containing elevated levels of CoA. Am J Physiol 1986;19: H351-9.
26. 13C NMR studies in perfused rat hearts. J Biol Chem 1983;258:13785-94.
27. Weiss RG, Gloth ST, Kalik-Filho R, et al. Indexing tricarboxylic acid cycle flux in intact hearts by carbon-13 nuclear magnetic resonance. Circ Res 1992;70:392-408.
28. Malloy CR, Sherry AD, Jeffery FMH. Carbon flux through citric acid cycle pathways in perfused heart by 13C NMR spectroscopy. FEBS Lett 1987;212:58-62.
29. 13C NMR. Magn Reson Med 1993;30:262-6.
30. Cohen DM, Bergman RN. Syntax: a rule-based stochastic simulation of the time varying concentrations of positional isotopomers of metabolic intermediates. Comput Biomed Res 1994;27:130-47.
31. 13C NMR spectroscopy and non-linear squares analysis. J Biol Chem 1995;270: 7999-8008.
32. 13C NMR spectra: metabolic flux, regulation, and compartmentation in hearts. Biophys J 1995;69:2090-102.
33. Lewandowski ED. Metabolism heterogeneity of carbon substrate utilization in mammalian heart: NMR determinations of mitochondrial versus cytosolic compartmentation. Biochemistry 1992;31: 8916-23.
34. Yu X, White LT, Alpert NM, et al. Subcellular metabolite transport and carbon isotope kinetics in the intramyocardial glutamate pool. Biochemistry 1996;35:6963-8.
35. Damico LA, White LT, Yu X, et al. Chemical versus isotopic equilibrium and the metabolic fate of glycolytic end products in the heart. J Mol Cell Cardiol 1996;28:989-99.
36. McNulty PH, Sinusas AJ, Cox S, et al. Glucose metabolism distal to a critical coronary stenosis in a canine model of low flow myocardial ischemia. J Clin Invest 1996;98:62-9.
37. Bing RJ. The metabolism of the heart. Harvey Lect 1955;50:27-70.
38. Schelbert HR. Myocardial ischemia and clinical applications of positron emission tomography. Am J Cardiol 1989;64:46E-53E.
39. Schwaiger M, Hicks RJ. The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991;32: 565-78.
40. Gambhir SS, Schwaiger M, Huang SC, et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med 1989;30:359-60.
41. Bergmann SR. Clinical applications of assessments of myocardial substrate utilization with positron emission tomography. Mol Cell Biochem 1989;88:201-9.
42. 11C] acetate as a tracer for non invasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation 1990;81:1594-605.
43. Brown MA, Myears DW, Bergmann SR. Non invasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron tomography. J Am Coll Cardiol 1988;12:1054-63.
44. Gropler G, Siegel B, Sampathkumaran K, et al. Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. J Am Coll Cardiol 1992; 19:989-97.
45. Taki J, Nakajima K, Matsunari I, et al. Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: assessment with iodine-123-Iabelled beta-methyl-branched fatty acid. Eur J Nucl Med 1995; 22:1385-92.
46. 11C-palmitate. Circulation 1977;55:66-73.
47. Hashimoto A, Nakata T, Tsuhihasi K, et al. Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am J Cardiol 1996;77:25-30.
48. 14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.
49. 18F-2-deoxy-2-fluoro-D-glucose. Am J Physiol 1990;259:H1022-31.
50. 18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation 1995;91:235-44.